Quark Venture and GF Securities Launch US$500M Global Health Sciences Venture Fund

Quark Venture Inc., a Vancouver, B.C.-based venture capital firm, and GF Securities Company Limited, a Chinese investment bank, are jointly establishing a new US$500m global health sciences venture fund.

Based in Vancouver, the fund will invest globally in a diversified portfolio of innovative biotechnology and health sciences companies.

Investments have already started with the first close of US$100m.

Led by Chief Executive Officer Karimah Es Sabar and Chairman Jesson Chen, Quark Venture has just announced a US$30m investment in Vancouver-based Methylation Sciences, a clinical-stage pharmaceutical company that is advancing a therapy for adjunctive treatment of Major Depressive Disorder.



Join the discussion